Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.
[dystrophic epidermolysis bullosa]
Patients
with
recessive
dystrophic
epidermolysis
bullosa
(
RDEB
)
have
incurable
skin
fragility
,
blistering
,
and
skin
wounds
due
to
mutations
in
the
gene
that
codes
for
type
VII
collagen
(
C
7
)
that
mediates
dermal-epidermal
adherence
in
human
skin
.
In
this
study
,
we
evaluated
if
topically
applied
human
recombinant
C
7
(
rC
7
)
could
restore
C
7
at
the
dermal-epidermal
junction
(
DEJ
)
and
enhance
wound
healing
.
We
found
that
rC
7
applied
topically
onto
murine
skin
wounds
stably
incorporated
into
the
newly
formed
DEJ
of
healed
wounds
and
accelerated
wound
closure
by
increasing
re
-epithelialization
.
Topical
rC
7
decreased
the
expression
of
fibrogenic
transforming
growth
factor
-β
2
(
TGF-β
2
)
and
increased
the
expression
of
anti-fibrogenic
TGF-β
3
.
These
were
accompanied
by
the
reduced
expression
of
connective
tissue
growth
factor
,
fewer
α
smooth
muscle
actin
(
α-
SMA
)
-
positive
myofibroblasts
,
and
less
deposition
of
collagen
in
the
healed
neodermis
,
consistent
with
less
scar
formation
.
In
addition
,
using
a
mouse
model
in
which
skin
from
C
7
knock
out
mice
was
grafted
onto
immunodeficient
mice
,
we
showed
that
applying
rC
7
onto
RDEB
grafts
with
wounds
restored
C
7
and
anchoring
fibrils
(
AFs
)
at
the
DEJ
of
the
grafts
and
corrected
the
dermal-epidermal
separation
.
The
topical
application
of
rC
7
may
be
useful
for
treating
patients
with
RDEB
and
patients
who
have
chronic
skin
wounds
.
Diseases
Validation
Diseases presenting
"growth factor"
symptom
22q11.2 deletion syndrome
achondroplasia
adrenal incidentaloma
aniridia
cadasil
cholangiocarcinoma
coats disease
dedifferentiated liposarcoma
dentin dysplasia
dentinogenesis imperfecta
dystrophic epidermolysis bullosa
esophageal carcinoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
holt-oram syndrome
inclusion body myositis
kallmann syndrome
krabbe disease
liposarcoma
lymphangioleiomyomatosis
oculocutaneous albinism
oral submucous fibrosis
pleomorphic liposarcoma
primary effusion lymphoma
primary hyperoxaluria type 1
severe combined immunodeficiency
systemic capillary leak syndrome
von hippel-lindau disease
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom